Clostridium difficile is a gram-positive, spore-forming, anaerobic, nosocomial pathogen affecting hospitalized patients taking long-term antibiotics. The bacterium is responsible for over 500,000 cases and 29,000 deaths annually (Lessa et al., 2015), with ~ $3 billion in health-care costs (O\u27Brien et al., 2007). There has been the emergence of a new hypervirulent strain of C. difficile known as North American Pulsotype 1 (NAP1), which is responsible for severe infections. Further, an increase in the incidence of C. difficile infections outside of hospital environments (Hensgens et al., 2012; McDonald et al., 2006; Rupnik et al., 2009) is observed. It is reported that 32% of all C. difficile illnesses in the United States are community as...
The use of antimicrobial agents and acquired resistances explains in part the emergence and spreadin...
Clostridioides difficile (C. difficile) is an opportunistic spore-forming intestinal pathogen, mainl...
Abstract: Clostridium difficile is a global nosocomial pathogen associated with increased morbidity ...
Clostridium difficile is a gram-positive, spore-forming, anaerobic, nosocomial pathogen affecting ho...
Clostridium difficile is a significant pathogen causing a toxin-mediated enteric disease in humans a...
Community-acquired Clostridium difficile infections have recently been increasing in incidence and s...
AbstractClostridium difficile is a critically important cause of disease in humans, particularly in ...
Introduction: Clostridium difficile is a spore-forming pathogen considered as a major cause of enter...
Background For over 4 decades, Clostridium difficile has been a significant enteric pathogen of h...
Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life th...
Clostridium difficile (CD) is an infectious disease that has a direct impact on our healthcare resou...
Introduction: Clostridioides difficile is a motile, gram-negative, toxin-producing bacteria responsi...
Clostridium difficile is an important enteric pathogen of humans and food animals. Recently it has b...
Clostridium difficile is an anaerobic, spore-forming bacterium that remains the main cause of nosoco...
Graduation date: 2016About 48 million cases of Foodborne illnesses (FBIs) are estimated to occur eve...
The use of antimicrobial agents and acquired resistances explains in part the emergence and spreadin...
Clostridioides difficile (C. difficile) is an opportunistic spore-forming intestinal pathogen, mainl...
Abstract: Clostridium difficile is a global nosocomial pathogen associated with increased morbidity ...
Clostridium difficile is a gram-positive, spore-forming, anaerobic, nosocomial pathogen affecting ho...
Clostridium difficile is a significant pathogen causing a toxin-mediated enteric disease in humans a...
Community-acquired Clostridium difficile infections have recently been increasing in incidence and s...
AbstractClostridium difficile is a critically important cause of disease in humans, particularly in ...
Introduction: Clostridium difficile is a spore-forming pathogen considered as a major cause of enter...
Background For over 4 decades, Clostridium difficile has been a significant enteric pathogen of h...
Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life th...
Clostridium difficile (CD) is an infectious disease that has a direct impact on our healthcare resou...
Introduction: Clostridioides difficile is a motile, gram-negative, toxin-producing bacteria responsi...
Clostridium difficile is an important enteric pathogen of humans and food animals. Recently it has b...
Clostridium difficile is an anaerobic, spore-forming bacterium that remains the main cause of nosoco...
Graduation date: 2016About 48 million cases of Foodborne illnesses (FBIs) are estimated to occur eve...
The use of antimicrobial agents and acquired resistances explains in part the emergence and spreadin...
Clostridioides difficile (C. difficile) is an opportunistic spore-forming intestinal pathogen, mainl...
Abstract: Clostridium difficile is a global nosocomial pathogen associated with increased morbidity ...